Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
Figure 6
Focused drug combination cytotoxicity. The grayscale dots in the figure demonstrate percent cell death of PC3 and DU145 with āā/ combination settings.